21.19USD-5.27%Mkt Cap: 3.39B $P/E: —4d ago
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a su…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/B
Pricier
1M Perf
Lower
$192.35BUSDP/E 28.4
$137.04BUSDP/E 37.5
$46.27BUSDP/E 44.7
$44.57BUSDP/E 41.5
$40.64BUSD
$37.20BUSDP/E 48.3
$36.91BUSDP/E 26.2
$34.38BUSDP/E 25.6
$29.40BUSDP/E 35.4
$26.44BUSDP/E 30.8
$23.63BUSDP/E 23.6
$23.32BUSDP/E 25.2
$22.39BUSD
$16.14BUSDP/E 35.6
$12.93BUSDP/E 26.9
$12.60BUSDP/E 54.3
$11.15BUSD
$8.92BUSDP/E 20.8
$6.22BUSD
$5.68BUSDP/E 228.5
$5.42BUSD
$5.09BUSDP/E 43.6
$4.63BUSDP/E 53.7
$3.77BUSDP/E 26.7
$2.96BUSD
$2.05BUSD
$1.97BUSD
$1.53BUSDP/E 38.7
$1.55BUSDP/E 23.5
$1.50BUSD
$1.50BUSD
$1.13BUSD
$1.02BUSDP/E 21.3
$734.29MUSD
$645.18MUSDP/E 42.0
$607.49MUSD
$569.52MUSD
$300.57MUSDP/E 3.0
$290.61MUSD
$226.27MUSD
$182.12MUSD
$141.76MUSD
$120.20MUSDP/E 19.1
$106.30MUSD
$97.25MUSD
$94.30MUSDP/E 18.1
$80.04MUSD
$58.94MUSD
$45.15MUSD
$33.01MUSD
$30.57MUSD
$22.69MUSD
$18.66MUSD
$12.29MUSD
$12.18MUSD
$9.96MUSDP/E 62.5
$9.42MUSD
$9.20MUSD
$6.29MUSD
$6.08MUSD
$5.13MUSD
$5.08MUSD
$5.06MUSD
$3.86MUSDP/E 2.8
$3.69MUSD
$3.29MUSD
$2.79MUSD
$2.11MUSD
$1.01MUSD
$314.2KUSDP/E Infinity
$56.1KUSD
Indicators:|
Key Statistics
Company
Market Cap3.39B $
Enterprise Value3.43B $
Revenue (TTM)295.41M $
Gross Profit205.62M $
Net Income (TTM)-59.50M $
Revenue/Share1.927 USD
Last Price21.19 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees624
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS00650F1093
Valuation
P/E (Trailing)—
P/E (Forward)-84.83
PEG—
EV/EBITDA-115.18
EV/Revenue11.61
P/S11.62
P/B15.83
EPS (TTM)-0.32
EPS (Forward)-0.25
52W Range
9.95587% of range22.80
52W High22.80 USD
52W Low9.955 USD
Profitability
Gross Margin74.24%
Oper. Margin-27.10%
EBITDA Margin-10.08%
Profit Margin-21.48%
ROE-27.19%
ROA-11.60%
Growth
Revenue Growth35.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.99M $
CapEx (TTM)2.96M $
FCF Margin5.45%
FCF Yield0.47%
Net Debt-10.15M $
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity0.36
Current Ratio3.35
Quick Ratio3.08
Book Value/Sh1.355 USD
Cash/Share1.364 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.29 USD
Upside (mean)-4.3%
Target Range18.00 USD – 22.00 USD
$18.00-4.3% to mean$22.00
# Analysts7
Ownership
Shares Out.160.04M
Float125.15M
Insiders1.84%
Institutions96.34%
Short Interest
Short Ratio3.5d
Short % Float6.03%
Short % Out.4.78%
Shares Short7.65M
Short (prev mo.)8.90M
Technical
SMA 5015.46 (+37.0%)
SMA 20015.66 (+35.3%)
Beta2.15
S&P 52W Chg20.05%
Avg Vol (30d)2.94M
Avg Vol (10d)5.11M
Technical Indicators
RSI (14)67.9
MACD1.6247
MACD Signal1.2339
MACD Hist.+0.3908
BB Upper22.15 USD
BB Middle18.17 USD
BB Lower14.19 USD
BB Width43.79%
ATR (14)1.252 USD
Vol Ratio (20d)0.88x